Is Pirfenidone/Asreliable available in China?
Pirfenidone/Pirfenidone is a specific anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a progressive lung disease characterized by scarring and hardening of lung tissue, leading to a gradual decline in respiratory function and seriously affecting patients' quality of life and survival. The drug slows down the process of pulmonary fibrosis by inhibiting fibrosis-related biomarkers, such as transforming growth factor beta (TGF-β), cytokines, etc., thereby improving patients' lung function and quality of life.

The use of pirfenidone usually needs to be carried out under the guidance of a professional doctor, because its therapeutic effect and safety may be affected by individual differences among patients. In clinical use, doctors will develop personalized treatment plans based on the patient's specific situation, including the severity of the condition, concomitant diseases and the patient's overall health. In addition, patients need to undergo regular monitoring when using this drug to detect possible side effects and adjust the treatment plan in a timely manner.
Regarding the side effects of pirfenidone, common adverse reactions include digestive system problems (such as diarrhea, nausea, vomiting), skin reactions (such as rash, itching), and abnormalities in liver function indicators. Therefore, during medication, patients need to regularly check liver function and communicate closely with their doctor to ensure medication safety.
In China, the original drug pirfenidone has been approved for marketing and included in Class B medical insurance, which means that patients who meet the indications can enjoy certain medical insurance reimbursement policies when receiving treatment. This policy has reduced the financial burden on patients to a certain extent and improved the accessibility of drugs. According to market information, the price of pirfenidone per box of 100mg and 54 tablets is approximately RMB 500. Considering the long-term use of the drug, patients need to purchase it regularly, which makes the overall treatment cost relatively high. However, the support of medical insurance can help alleviate this pressure.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)